Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: A randomised, double-blind, placebo-controlled trial

Trial Profile

Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: A randomised, double-blind, placebo-controlled trial

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2009

At a glance

  • Drugs Azithromycin; Clarithromycin
  • Indications Streptococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top